96.78
Precedente Chiudi:
$95.51
Aprire:
$95.51
Volume 24 ore:
396.29K
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.61B
Reddito:
$5.82B
Utile/perdita netta:
$-373.54M
Rapporto P/E:
-4.2926
EPS:
-22.546
Flusso di cassa netto:
$-87.01M
1 W Prestazione:
+2.84%
1M Prestazione:
-15.73%
6M Prestazione:
+759.31%
1 anno Prestazione:
+343.13%
Agilon Health Inc Stock (AGL) Company Profile
Nome
Agilon Health Inc
Settore
Industria
Telefono
562-256-3800
Indirizzo
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, EHC, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
AGL
Agilon Health Inc
|
96.78 | 1.64B | 5.82B | -373.54M | -87.01M | -22.55 |
|
HCA
Hca Healthcare Inc
|
414.03 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
259.93 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.35 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
125.81 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
183.69 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-25 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-04-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-01-10 | Iniziato | Needham | Hold |
| 2024-12-16 | Iniziato | Macquarie | Neutral |
| 2024-12-11 | Iniziato | Bernstein | Mkt Perform |
| 2024-11-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-04-22 | Iniziato | Citigroup | Neutral |
| 2024-03-06 | Iniziato | Barclays | Underweight |
| 2024-02-26 | Downgrade | Jefferies | Buy → Hold |
| 2024-02-26 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Downgrade | Stifel | Buy → Hold |
| 2024-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Downgrade | Truist | Buy → Hold |
| 2023-12-11 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Iniziato | The Benchmark Company | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | In-line |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-09-14 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-09-12 | Iniziato | Goldman | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-06-24 | Iniziato | BTIG Research | Neutral |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2021-10-20 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-05-11 | Iniziato | William Blair | Outperform |
| 2021-05-10 | Iniziato | BofA Securities | Buy |
| 2021-05-10 | Iniziato | Deutsche Bank | Buy |
| 2021-05-10 | Iniziato | Goldman | Buy |
| 2021-05-10 | Iniziato | JP Morgan | Overweight |
| 2021-05-10 | Iniziato | Truist | Buy |
| 2021-05-10 | Iniziato | Wells Fargo | Overweight |
| 2021-05-10 | Iniziato | Wolfe Research | Outperform |
Mostra tutto
Agilon Health Inc Borsa (AGL) Ultime notizie
AGL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
agilon health inc (AGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
agilon health inc (AGL) Balance Sheet - TradingKey
agilon health inc (AGL) Cash Flow - TradingKey
AGL|agilon health inc|Price:98.000|Chg%:-2.450 - TradingKey
AGL|agilon health inc|Price:98.430| - TradingKey
What Does the New CEO Appointment Mean for Agilon Health (AGL) - Kavout | AI
agilon health, inc. (AGL) Stock Price, News, Quote & History - Yahoo! Finance Canada
AGL Downgraded by Citigroup -- Price Target Raised to $105 - GuruFocus
agilon health inc (AGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
agilon health, inc. Stock 12‑Month Price Target Raised to $73.36, Implies 39% Downside - TradingView
Why agilon health (AGL) Shares Are Falling Today - Yahoo Finance
Citi Downgrades Agilon Health(AGL.US) to Sell Rating, Raises Target Price to $105 - Moomoo
Citigroup Downgrades Agilon health to Sell From Neutral, Adjusts Price Target to $105 From $80 - marketscreener.com
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Agilon Health | 8-K: Current report - Moomoo
Why Is AGL Stock Rising Today? - Stocktwits
Agilon health, inc. Announces Termination of Girish Venkatachaliah as Chief Technology Officer, Effective August 1, 2026 - marketscreener.com
Agilon Health Announces CTO Transition and Consulting Role - TipRanks
agilon CTO Girish Venkatachaliah to Depart Aug 1, 2026 with Severance and Consulting Arrangement - TradingView
AGL stock holds as Agilon Health revenue and loss frame the 2026 outlook - Ad-hoc-news.de
agilon health inc. (AGL) Q1 2026 Earnings: EPS Surges Past Estimates Amidst Market SkepticismEarnings Manipulation Risk - dars.gov.et
agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a -41.38% Potential Downside - DirectorsTalk Interviews
Agilon Health (NYSE:AGL) Stock Price Down 5%Time to Sell? - MarketBeat
agilon health (AGL) Proxy filing Summary - Quartr
Timothy Patrick O'rourke Net Worth (2026) - GuruFocus
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $141 - Moomoo
Agilon health stock hits 52-week high at 126.0 USD By Investing.com - Investing.com South Africa
Agilon health stock hits 52-week high at 126.0 USD - Investing.com
The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality - Sahm
Price to book forward of agilon health, inc. – NYSE:AGL - TradingView
Price to book forward of agilon health, inc. – BOATS:AGL - TradingView
agilon health ACOs achieve $229M in savings under Medicare program - Investing.com India
AGL stock steadies as Agilon Health follows its care model - Ad-hoc-news.de
Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4% - TradingView
agilon health ACOs achieve $229M in savings under Medicare program By Investing.com - Investing.com South Africa
agilon health Reports ACO REACH Model Results for 2024 Performance Year - Business Wire
Barclays Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Press Release: Agilon Health Sets Date to Report Second Quarter 2026 Financial Results - 富途牛牛
agilon health Sets Date to Report Second Quarter 2026 Financial Results - Business Wire
agilon health sets Aug. 5 call for second-quarter results - Stock Titan
How Investors Are Reacting To agilon health (AGL) Scrutiny On Value-Based Medicare Advantage Execution - Yahoo Finance
Agilon Health stock stays tied to Medicare Advantage trends. - Ad-hoc-news.de
Deutsche Bank upgrades agilon health stock rating on raised guidance - Investing.com
Jefferies upgrades agilon health stock rating on rate visibility - Investing.com
AGL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Agilon Health (NYSE:AGL) Faces A Value Care Test - Kalkine Media
Form 4 agilon health Inc For: 2 July By Investing.com - Investing.com Nigeria
CFO of agilon health (AGL) uses 2,311 shares to cover RSU taxes - Stock Titan
Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) - The National Law Review
Agilon Health Inc Azioni (AGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Agilon Health Inc Azioni (AGL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):